Multimodality imaging of cardiothoracic lymphoma

• Published in: European journal of radiology 2014-08, Vol.83 (8), p.1470-1482
• Main Authors: Carter, Brett W, Wu, Carol C, Khorashadi, Leila, Godoy, Myrna C.B, de Groot, Patricia M, Abbott, Gerald F, Lichtenberger III, John P
• Format: Article
• Language: English
• Subjects: Cardiac; Humans; Lymphoma; Lymphoma - diagnosis; Lymphoma - pathology; MRI; Multimodal Imaging; PET/CT; Radiology; Thoracic; Thoracic Neoplasms - diagnosis; Thoracic Neoplasms - pathology
• ISSN: 0720-048X; 1872-7727
• DOI: 10.1016/j.ejrad.2014.05.018

Abstract Lymphoma is the most common hematologic malignancy and represents approximately 5.3% of all cancers. The World Health Organization published a revised classification scheme in 2008 that groups lymphomas by cell type and molecular, cytogenetic, and phenotypic characteristics. Most lymphomas affect the thorax at some stage during the course of the disease. Affected structures within the chest may include the lungs, mediastinum, pleura, and chest wall, and lymphomas may originate from these sites as primary malignancies or secondarily involve these structures after arising from other intrathoracic or extrathoracic sources. Pulmonary lymphomas are classified into one of four types: primary pulmonary lymphoma, secondary pulmonary lymphoma, acquired immunodeficiency syndrome-related lymphoma, and post-transplantation lymphoproliferative disorders. Although pulmonary lymphomas may produce a myriad of diverse findings within the lungs, specific individual features or combinations of features can be used, in combination with secondary manifestations of the disease such as involvement of the mediastinum, pleura, and chest wall, to narrow the differential diagnosis. While findings of thoracic lymphoma may be evident on chest radiography, computed tomography has traditionally been the imaging modality used to evaluate the disease and effectively demonstrates the extent of intrathoracic involvement and the presence and extent of extrathoracic spread. However, additional modalities such as magnetic resonance imaging of the thorax and18 F-FDG PET/CT have emerged in recent years and are complementary to CT in the evaluation of patients with lymphoma. Thoracic MRI is useful in assessing vascular, cardiac, and chest wall involvement, and PET/CT is more accurate in the overall staging of lymphoma than CT and can be used to evaluate treatment response.